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srGAP proteins regulate cell migration and morpho-
genesis by shaping the structure and dynamics of
the cytoskeleton and membranes. First discovered
as intracellular effectors for the Robo1 axon-guid-
ance receptor, srGAPs were later identified as inter-
acting with several other nuclear and cytoplasmic
proteins. In all these cases, the srGAP SH3 domain
mediates protein-protein interactions by recognizing
a short proline-rich segment on the cognate-binding
partner. However, as interactions between the iso-
lated SH3 domain and a selected set of ligands
show weak affinity and low specificity, it is not clear
how srGAPs are precisely recruited to their signaling
sites. Here, we report a two-component molecular
mechanism that regulates ligand binding to srGAP2
by on the one hand dramatically tightening their as-
sociation and on the other, moderately autoinhibiting
and restricting binding. Our results allow the design
of point mutations for better probing of srGAP2
activities, and may facilitate the identification of
new srGAP2 ligands.
INTRODUCTION
The four human Slit-Robo GTPase-activating proteins (srGAPs)
control the migration and morphology of cells by coupling and
coordinating remodeling reactions of the plasma membrane
and the actin-based cytoskeleton. srGAPs accomplish this com-
plex task through a unique domain composition of an extended
F-BAR, followed by RhoGAP and SH3 domains that mediate
membrane association and deformation, cytoskeleton remodel-
ing, and protein-protein interactions, respectively (Guerrier et al.,
2009). A possible mechanism of action of srGAP proteins was
presented for srGAP3 (Endris et al., 2011), whereby srGAP3
recruitment to leading edges of cellular lamellipodia and focal
adhesions relies on the association of both the F-BAR and SH3
domains with protruding membranes and lamellipodia-specificStructure 23, 1989–20proteins. The accurate subcellular localization of srGAP3 allows
its RhoGAP domain to effectively inactivate the small GTPase
Rac1, which, in turn, leads toWAVE1 downregulation, the subse-
quent breakdown of local actin cytoskeleton structures, and the
retraction of membrane protrusions. This mechanism portrays
srGAPs as proteins that are recruited to protruding cellular sites
to restrict further expansion. The functions of F-BAR (FES-CIP4
homology) domains, aswell as those of the other members of the
BAR superfamily (i.e., BAR [Bin/amphiphysin/RVS], I-BAR [in-
verse BAR], and N-BAR [N-terminal BAR] domains), are directly
linked to their three-dimensional (3D) structure and oligomeric
organization. They all form membrane-binding dimers that can
induce and/or stabilize membrane curvatures. The radius and di-
rection of the membrane curvature (whether related to cellular
invagination, evagination, or flat surfaces) is correlated to the
molecular curvature of the membrane-binding surface of the
BAR dimer and the oligomeric arrangement of the BAR dimers
in a larger assembly of membrane-associated lattices (Frost
et al., 2009). Indeed, the F-BAR domains of srGAP proteins
were shown to induce membrane protrusions. Most notably,
the F-BAR domain of srGAP2 induces tubular membrane protru-
sions in vitro, in COS-7 cells and primary neuronal cell cultures,
and endogenous srGAP2 was detected in subcellular sites
distinguished by outward membrane protrusions, i.e., dendritic
spines and axonal growth cones (Carlson et al., 2011; Cou-
tinho-Budd et al., 2012; Guerrier et al., 2009; Yamazaki et al.,
2013; Yao et al., 2008).
srGAP proteins, like many other BAR superfamily members,
also include an SH3 domain that coordinates their localization
and activity with other signaling molecules and cytoskeleton
effectors (Qualmann et al., 2011). Accordingly, srGAP proteins
were initially discovered in a yeast two-hybrid screen as cyto-
plasmic effectors of the Robo1 axon-guidance receptor, where
a specific proline-rich cytoplasmic segment of Robo1, termed
cc3,wasshown tomediatebinding to theSH3domain of srGAP1,
2, and 3, while the rest of the Robo1 intracellular domain,
including theproline-richcc2 segment, didnot bind to the srGAPs
(Wong et al., 2001). However, later in vitro studies that investi-
gated srGAP2 interactions did not provide further convincing
corroboration for the Robo1-srGAP2 interaction. One study that
measured direct SPR (surface plasmon resonance) interactions
between synthetic Robo1-cc3 peptides of various lengths and00, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 1989
Figure 1. Domain Organization and Dimerization of srGAP Proteins
(A) Human srGAP2, srGAP4, and srGAP2 deletion mutants used in this study. In the scheme the F-BAR, RhoGAP, and SH3 domains are indicated and appear as
colored shapes. The SH3 C0 extension is colored cyan.
(B andC) Size-exclusion chromatography by Superdex 200 26/60 (standardmolecular weights indicated) (B) and cross-linking by glutaraldehyde gradient fixation
(GraFix) analyzed by SDS-PAGE (C) of purified srGAP2 and srGAP4 demonstrate F-BAR-dependent dimerization of srGAP proteins, while the 2SH3e and 2RSe
constructs that lack the F-BAR domain are eluted as monomers.the isolatedSH3domainsof srGAP1, 2, and 3did not detect bind-
ing with most peptides and only a weak and transient interaction
(apparent KD of 5 mM) with one peptide (Li et al., 2006). A
different study that used photo-trapping to capture weak binding
partners for the SH3 domains of srGAP2 and srGAP4 (ARHGAP4)
did not report Robo1 as one of the identified ligands (Okada et al.,
2013). Instead, several other proline-rich proteins, e.g., the post-
synaptic scaffoldingproteinGephyrin and the nuclear telomerase
regulatorYLPM1,weredetected. These join agrowing list of other
putative srGAP effectors, such as the cytoskeletal organization
protein formin (Mason et al., 2011) and the scaffolding protein
WAVE-1 (Soderling et al., 2007), which were found to interact
and act through srGAP2 and srGAP3.
If, indeed, srGAPs bind so weakly to Robo1 while also being
capable of interacting with a large repertoire of potentially
competing partners, how can miswiring be avoided and accu-
rate signaling axes formed? In this study, we address these
questions by studying the molecular basis for protein-protein in-
teractions by srGAP2 using SH3-binding segments from three
different proteins (Robo1, Gephyrin, and YLPM1). Our investiga-
tions revealed an integrated two-component mechanism that
provides much stronger affinity and specificity to certain binding
partners. This is achieved by the cooperative involvement of the
F-BAR and RhoGAP domains in SH3 interactions, while restrict-1990 Structure 23, 1989–2000, November 3, 2015 ª2015 Elsevier Ltding ligand access through an autoinhibitory switch that is sensi-
tive to the local concentration of srGAP2.
Taken together, our results will allow the identification of
genuine srGAP-binding partners in future screens by using
the F-BAR-RhoGAP-SH3 module instead of the isolated SH3
domain, and strongly support the existence of a Robo1-srGAP
signaling axis. Also, this study reveals an SH3 carboxy extension
segment that, depending on srGAP2 concentration, can bind to
the SH3 domain in cis, or to a neighboring srGAP2 molecule in
trans. Thus, the SH3 carboxy extension might actually serve
two different purposes: preventing the binding of non-specific
ligands, and mediating intermolecular contacts in the srGAP2
membrane-associated lattice.
RESULTS
Limited Proteolysis Analysis of srGAP2 Reveals a Stable
SH3 Carboxy Extension
We used Escherichia coli for the recombinant expression of
human srGAP proteins. As expected, gel-filtration and gradient
fixation analyses showed that srGAP2 and srGAP4 are dimers
in solution, consistent with F-BAR-domain-mediated dimer-
ization (Figures 1 and S1). Using limited trypsin digestion fol-
lowed by liquid chromatography-electrospray ionization-massAll rights reserved
Table 1. Crystallographic Statistics
Data Collection Statistics
Beamline (ESRF) ID-29 ID-29
Wavelength (A˚) 0.976 0.976
Space group P212121 P21
Unit cell parameters (A˚) a = 31.30,
b = 52.54,
c = 92.51
a = 49.51,
b = 31.35,
c = 62.83;
b = 113.07
Total reflectionsa 59,638 (4,560) 98,309 (9,190)
Unique reflectionsa 12,959 (1,177) 15,014 (1,410)
Completeness (%)a 98.4 (91.2) 97.13 (95.01)
Rmeas (%)
a,b 11.6 (60.6) 11.37 (67.2)
Mean I/sa 10.77 (2.11) 10.55 (3.06)
Resolution range (A˚) 46.26–1.87 57.81–1.73
CC1/2
a 0.99 (0.86) 0.99 (0.93)
Refinement Statistics
Rwork (%)
a 0.22 (0.36) 0.18 (0.24)
Rfree (%)
a 0.25 (0.37) 0.22 (0.24)
No. of non-hydrogen atoms 1,366 1,427
Macromolecules 1,280 1,317
Water 71 110
Protein residues 160 167
Root-mean-square (bonds) 0.013 0.015
Root-mean-square (angles) 1.56 1.61
Ramachandran favored (%) 99 97
Ramachandran outliers (%) 0 1.2
Clashscore 1.97 2.71
Average B factor 34.00 27.9
RCBS PDB code 4RTT 4RUG
aValues of the highest-resolution shell are given in parentheses.
bRmeas = Sh[m/(m  1)]1/2 SijIh,i  <Ih>j/ShSiIh,i.spectrometry analysis, we probed the structural features of
srGAP2 by identifying sites with enhanced backbone flexibility.
The most prominent protein fragment (497 KQDS....VTAR 815)
that resisted a 20-hr digestion period spans the RhoGAP and
SH3domains,withacarboxyextensionof30 residues (FigureS1).
This extension (786 DTEDGVVERSSPKSEIEVISEPPEEKVTAR
815), which harbors three putative trypsin digestion sites
(. ERvS. PKvS. EKvV.), is predicted to have a disordered
secondary structure; therefore, its resistance to overnight diges-
tion was unexpected.
Crystal Structure of srGAP2 SH3e
Our limited proteolysis analysis suggested that the SH3 carboxy
extension forms close contacts with the RhoGAP-SH3 domains.
To reveal the nature of these interactions, we pursued high-res-
olution structural information, and were able to crystallize the
2SH3e construct (which stands for srGAP2 SH3, carboxy exten-
sion) (Figure 1A) and determine its 3D X-ray structure. Crystals of
two space groups (P2 and P212121) were obtained and diffracted
to maximal resolutions of 1.73 and 1.87 A˚, respectively (Table 1).
In both cases, two protein copies occupied one asymmetric unit
(Figure S2).Structure 23, 1989–20The general topology of the 2SH3e core domain is very similar
to those of several other SH3 domains, including p40phox and
c-Crk, which have available crystal structures in a complex
with polyproline ligands (PDB: 1W70 and 1CKA). The SH3
core domain (residues P730–Q785) has five b strands (b1–b5)
arranged as two antiparallel sheets, giving rise to a b-barrel
fold. The RT, N-Src, and distal loops connect the b1-b2, b2-b3,
and b3-b4 strands, respectively, while a short helix connects
b4 and b5 (Figure 2).
In most cases, SH3 (Src-homology 3) domains recognize
ligands that present a PxxP minimal consensus sequence,
where each proline binds to a reciprocal ‘‘Px’’ and ‘‘xP’’ hydro-
phobic ‘‘pocket’’ on the SH3 surface that, together, constitute
the ‘‘PxxP binding groove.’’ In some cases, additional binding
sites on the target SH3 surface (located outside the PxxP binding
groove), such as the ‘‘specificity pocket’’ and the ‘‘specificity
zone,’’ are also utilized (Zarrinpar et al., 2003). Based on a
comparison to the p40phox and c-Crk crystal structures, we as-
signed these clefts to the 2SH3e structure and identified tyrosine
781, tryptophan 765, and glutamate 746 to be key residues in the
Px, xP, and specificity pocket clefts, respectively (Figure 2).
Twenty-four of the carboxy extension residues, D786–E809,
are visible in the structure, and are subdivided into two seg-
ments; each includes a short helix flanked by loop connectives.
The first segment, which spans residues D786–P797, forms
close cis interactions, while the second segment (K798–E809)
interacts in trans with a symmetry-mate molecule, and is hence-
forth referred to as the SH3 C0 extension and by an ‘‘e’’ in the
construct acronyms. The C0-extension binding surface on the
symmetry-mate molecule spans the xP binding cleft and ex-
tends to the specificity zone (Figures 2 and 3 and Figure S3).
Three C0-extension residues (E800, V803, and I804) are located
on one face of a short helix (E800–S805) that directly interacts
with the specificity zone through hydrophobic and polar contact.
The four residues at the carboxy end of the C0 extension 806
EPPE 809 bind to the SH3 xP binding cleft in the same way
that polyproline ligands do.Most notably, P807 assumes a back-
bone carbonyl position that forms a hydrogen bond with the
indole secondary amine of W765, thereby mimicking a canonical
PxxP proline ligand position and function (Figures 2 and 3). As
P807 is conserved in srGAP2 paralogs and orthologs of most
chordate creatures, the possible functionality and interactions
of this residue are further emphasized. The similarity to canonical
SH3 polyproline ligands led us to view the C0 extension as a part
of an autoinhibitory mechanism aimed at restricting protein
binding to srGAP2.
C0-Extension Binding and Secondary Structure
We generated additional constructs of srGAP proteins that have
or lack the SH3 C0 extension: (1) 2BRSe (which stands for
srGAP2 F-BAR, RhoGAP, SH3, C0 extension) srGAP2, which is
truncated after the SH3 C0 extension; (2) 2BRS; (3) 2delB
(srGAP2, which lacks the F-BAR); (4) 2RSe; (5) 2RS; (6) 2SH3;
and (7) 4SH3 (SH3 of srGAP4). These constructs were success-
fully expressed in E. coli and purified, exhibiting high protein
stability and homogeneity, as evaluated by size-exclusion chro-
matography analysis. As expected, 2BRS and 2BRSe are di-
mers, based on gradient fixation analysis, while the constructs
lacking the F-BAR domain are monomeric (Figure 1).00, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 1991
Figure 2. Crystal Structure, Autoinhibition, and Dimerization of the srGAP2 SH3 Domain
(A) Sequence alignment and structural features of the srGAP2 SH3 domain region. Sequences of human srGAP2 orthologs and paralogs were manually aligned
and secondary structure elements assigned. Gray letters represent the SH3 core region, orange and cyan represent the connective loop and C0 extension,
respectively, and sequence identity is marked by dots. The residues involved in trans interaction with neighboring C0 extension are highlighted in yellow, and
residues involved with polyproline recognition in canonical SH3 domains are boxed in black, as represented by c-Crk standard structure (PDB: 1CKA). The key
proline 807 is highlighted in red.
(B) Ribbon and surface representation of the extended srGAP2 SH3 (2SH3e) determined at 1.73 A˚ resolution. The SH3 core and C0 extension are colored as in (A)
with gray and cyan, respectively. The canonical polyproline binding groove surface is highlighted in red, and the Px, xP, specificity zone, and specificity pocket are
labeled.
(C) A crystallographic symmetry-related dimer of 2SH3e shows how one molecule’s C0 extension docks onto the specificity and xP pockets of a neighbor 2SH3e
molecule. A simplified illustration of the 2SH3e dimer portrays the PxxP binding groove as a light-gray crescent, with Y781 (Px pocket) and W765 (xP pocket)
appearing as sticks. The C0 extension (cyan coil) of the ‘‘donor’’ molecule binds to a neighbor ‘‘acceptor’’ molecule, while the C0 extension of the acceptor cannot
reach the binding site on the donor and, therefore, appears unfolded in a dimer.
(D) Modeled C0-extension binding in cis. The C0 extension can reach the specificity zone and xP pocket at the expense of several atomic interactions that exist in
the trans interaction.
(legend continued on next page)
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Figure 3. The C0 Extension Utilizes Polypro-
line Mimicry to Inhibit Protein Binding to
srGAP2
(A) The crystal structure of c-Crk (p38) N-terminal
SH3domain (PDB1CKA)withC3Gpeptidepresents
a ‘‘canonical’’ SH3-polyproline complex. The yellow
circle highlights the xP pocket tryptophan and its
association with the C3G peptide proline residues.
(B) The crystal structure of 2SH3e with the same
orientation as (A) reveals how the C0 extension
(cyan) mimics a polyproline ligand. Note how
prolines 807 and 808 assume positions similar to
that of the C3G ligand of the c-Crk structure.
(C) A 2Fo-Fc electron density map contoured to
1.3s, focusing on the xP pocket site and with the
same orientation and color code as in (B).
(D) Microscale thermophoresis (MST) titration
curves and apparent KD values for Robo1-cc3
binding to srGAP2 constructs. Measured thermo-
phoresis values (symbols) fitted to a one-to-one
binding model (solid lines). Binding is strongest to
the 2BRS and weakest to the 2SH3 constructs.
Note that for all constructs, the C0 extension
moderately inhibits binding, and that the point
mutation P807E abolishes the inhibitory effect.In both the orthorhombic and monoclinic crystal lattices of
2SH3e, the C0 extension interacts in trans with the SH3 core of
a symmetry-mate molecule. We investigated whether this trans
interaction also occurs in solution, and used CG-MALS (compo-
sition-gradient multi-angle static light scattering) to compare the
oligomeric state of 2SH3e with that of 2SH3. The results show
that while both proteins are virtually monomeric at concentra-
tions of up to 10 mM, 2SH3e has about 10% dimeric fraction at
100 mM and a calculated dimerization dissociation constant of
1.39 mM. By contrast, 2SH3, which lacks the C0 extension, has
a much weaker dimerization constant of 5.1 mM (Figure 2).
Next, we considered whether the C0 extension can also bind in
cis. Superimposing the C0 extension to the cis position shows
that such a conformation is sterically possible (Figure 2) at the
expense of altering the positions of two residues: K799 and
E800. Based on this analysis, we conclude that while a C0-exten-
sion interaction in cis is possible, a trans interaction may bemore
favorable, especially at high local concentration conditions of
srGAP2. It is important to note that in the context of a dimeric
interaction, where the C0 extension of a ‘‘donor’’ molecule binds
in trans to an ‘‘acceptor’’ molecule, the short length of the C0
extension and its spatial arrangement prevent the C0 extension
of the acceptor to reach the binding site on the donor, which
would leave the donor unbound and fully exposed (Figure 2).(E) 2SH3e dimerization in solution is mediated by the C0 extension. Different concentrations of 2SH3 and 2S
angle light scattering (CG-MALS). The weight average molar masses were plotted as a function of concentra
the average molecular weight of the relevant concentration measured via the Calypso system, together wit
Each dataset is fitted with a nonlinear regression to a model of monomer-dimer equilibrium (solid line). D
regression fit are indicated for each protein.
Structure 23, 1989–2000, November 3, 2015We next calculated the binding affinity
of a synthesized C0-extension peptide to
2SH3 using intrinsic tryptophan fluores-cence intensity measurements, which are particularly useful in
our case because the boundC0 extension occludes the only tryp-
tophan (W765) of 2SH3e that is surface exposed (Figures 2
and 3). By titering increasing concentrations of a C0-extension
peptide (gcggKSEIEVISEPPEEKVT-813) to 2SH3 that was
maintained at a steady 6 mM concentration, we calculated an
apparent dissociation constant of 1.2 ± 0.4 mM (Figure S4).
This KD value is very similar to the 2SH3e dimerization dissocia-
tion constant of 1.39 mM that we measured using GC-MALS.
We next considered whether, like other characterized autoin-
hibitory segments, the C0 extension also undergoes an induced
helical transition upon interaction with its cognate-binding sur-
face. The crystallographic data show that a portion of the C0
extension has a helical conformation in the crystal, in contrast
to its predicted random-coil secondary structure. To test
whether this segment assumes a random-coil structure when
isolated, we measured a circular dichroism (CD) spectrum of
the C0-extension peptide in water. A second CD measurement,
in 40% trifluoroethanol (TFE) solution that induces hydrogen
bond formation, was conducted to determine the potential helic-
ity content of the peptide (Figure S5), as we previously demon-
strated (Opatowsky et al., 2004). Deconvolution of the CD
spectra (Greenfield, 2006) shows an all-coil structure in water
while having a 20% a-helicity in the mixed water/TFE solution,H3e were measured by composite-gradient multi-
tion (dots on the graph). Each data point represents
h MALS apparatus and a refractive index detector.
imerization constants (KD) calculated by nonlinear
ª2015 Elsevier Ltd All rights reserved 1993
Table 2. Kinetic Parameters
Microscale Thermophoresis Measurements: ApparentKD Values
in mM
srGAP2
Construct Robo1 cc3 Gephyrin YLPM1 Robo1 cc2
2SH3 6.95 ± 0.271 22.6 ± 1.58 2.53 ± 0.08
2SH3e 17.60 ± 1.21 40.90 ± 3.22 9.28 ± 0.61
2RS 1.59 ± 0.14
2RSe 4.16 ± 0.30
2delB 3.9 ± 0.2
2BRS 0.48 ± 0.01 0.712 ± 0.03 2.09 ± 0.1 41.40 ± 1.16
2BRSe 1.04 ± 0.05 3.170 ± 0.21 3.02 ± 0.13 NA
2BRSe
P807Q
0.32 ± 0.02 0.80 ± 0.04 1.54 ± 0.12
Surface Plasmon Resonance: Robo1 cc3 Binding Kinetics
srGAP Construct KD (mM) kon (M
1.s1) koff (s
1) c2 (RU2)
2SH3 6.19 196,000 2.57 2.48
2SH3e 13.10 333,000 2.06 3.62
2RS 1.15 330.3 0.00038 3.28
2RSe 4.49 398.8 0.00177 0.34
2BRS 0.22 4,560 0.00100 0.43
2BRSe 0.59 5,480 0.00325 10.3
4SH3 7.65 231,000 1.769 7.24
srGAP4 0.34 16,200 0.00553 12.5which corresponds exactly to the helical fraction of the C0 exten-
sion, as seen in the crystal structure. This implies that the C0
extension undergoes a coil-to-helix transition during its associa-
tion with the SH3 specificity zone.
The C0 Extension Inhibits Protein Binding to 2SH3e
We next measured the inhibitory effect that the C0 extension
imparts on the binding of srGAP2 to Robo1, Gephyrin, and
YLPM1. For these measurements, we used 23-residue-long
synthesized peptides that we N0-labeled with biotin and fluores-
cein. These peptides correspond to the Robo1-cc3, Gephyrin
E-domain, andYLPM1peptides (FigureS6). Tomeasure thebind-
ing affinities, we used microscale thermophoresis (MST) for all
three peptides and SPR only for Robo1-cc3; the summarized
results are presented in Table 2. All three peptides show 1.8- to
3.1-fold weaker KD values for 2SH3e association in comparison
with 2SH3, thereby demonstrating the autoinhibitory role of the
C0 extension (Figures 3 and S7). For all three peptides, binding af-
finities to 2SH3e and 2SH3 were weak. For example, Robo1-cc3
binds 2SH3 and 2SH3e with KD of 6.9 and 17.6 mM, respectively,
as determined by MST. SPR measurements of Robo1-cc3 were
consistent with the MST results, with KD of 6.19 and 13.1 mM for
2SH3 and 2SH3e, respectively (Table 2). The SPR binding and
release profile presents very rapid kon (3.33E+05 and 1.96E+05
[M1 s1]) and koff (2.06and2.57 [s
1]) values for Robo1-cc3bind-
ing to 2SH3 and 2SH3e, respectively (Table 2; Figures 2 and S7).
The F-BAR and RhoGAP Domains Modulate Binding
Kinetics
We also measured the binding affinities of the Robo1-cc3,
Gephyrin, and YLPM1 peptides to larger srGAP2 constructs1994 Structure 23, 1989–2000, November 3, 2015 ª2015 Elsevier Ltd(Figure 1A). As in the case of binding to the SH3 domain, all
the peptides showed weaker affinities for constructs that include
the C0 extension, further confirming its role in the autoinhibition of
ligand binding (Table 2; Figures 3 and S7). Also, it is clear that the
C0 extension alone restricts ligand binding to srGAP2, since a
construct that includes the entire carboxy terminal tail (2delB)
showed very similar Robo1-cc3 binding, as did a construct
(2RSe) lacking the long C0 tail.
Comparison of the KD values obtained for 2SH3with those ob-
tained for 2BRS revealed remarkably stronger Robo1-cc3 and
Gephyrin binding to the 2BRS constructs. The differences in
KD are not exactly the same for Robo1-cc3 and Gephyrin, and
range between a 13- and 33-fold increase in affinity, depending
on peptide, method of measurement (MST versus SPR), and
whether the srGAP2 construct has or lacks the C0 extension.
Unlike Robo1-cc3 and Gephyrin, only a mere 1.25- to 3-fold in-
crease in affinity was observed for YLPM1. Analysis of the SPR
measurements of Robo1-cc3 interaction with the 2BRS con-
structs revealed completely different binding and release ki-
netics compared with those of the 2SH3 constructs, where the
2SH3 constructs had about 100-times faster on-rates and
1,000-times faster off-rates than the 2BRS constructs (Table 2
and Figure 4). We also measured and compared the binding
kinetics of Robo1-cc3 to 4SH3 and srGAP4. The results were
very similar to those obtained for srGAP2, with weak (7.6 mM)
versus strong (0.34 mM) KD values for Robo1-cc3 binding to
4SH3 and srGAP4, respectively (Table 2, determined by SPR).
Also, the binding and release kinetic profiles of 4SH3 and
srGAP4 were similar to those of 2SH3 and 2BRS, demonstrating
fast versus slow interaction rates (Figure S7). These results prove
that the F-BAR and RhoGAP domains have a dramatic impact on
the binding kinetics of some ligands to srGAP2 and srGAP4,
facilitating relatively strong (submicromolar) interactions.
We further inquired what might be the specific roles of the
F-BAR and RhoGAP domains in modulating ligand binding to
srGAP2. To this end, we used SPR to measure the binding
kinetics of Robo1-cc3 to 2RSe and 2RS. We found that while
the off-rates for 2RS constructs are very similar to those for
2BRS (and slower than those for 2SH3), the on-rates are about
ten times slower, resulting in overall weaker binding affinities
in comparison with those of the 2BRS constructs (Table 2 and
Figure 4). A possible interpretation of these results is that the
F-BAR domain stabilizes the RhoGAP-SH3 interdomain orienta-
tion, which would otherwise be more flexible. The stabilized
RhoGAP-SH3 module forms an elaborate binding surface that
binds ligands stronger and slower than the isolated 2SH3.
The SH3 Domain of srGAP2 Is, Nevertheless, Necessary
for Robo1-cc3 Binding
Given the profound difference in ligand-binding properties be-
tween isolated SH3 domains of srGAP2 and 4 to constructs
that also include the F-BAR and RhoGAP domains, we asked
whether polyproline ligand binding to srGAP proteins actually re-
lies on the SH3 domain or is mostly independent of SH3. For this,
we separately mutated the two conserved SH3 residues that
constitute the Px and xP clefts, tyrosine 781 and tryptophan
765, respectively (Figures 2, 3, and 4). Y781A andW765A substi-
tutes were introduced into 2BRS, expressed and purified under
the same conditions (Figure S1), and measured for Robo1-cc3All rights reserved
Figure 4. The F-BAR, RhoGAP, and SH3 Domains Cooperatively Participate in Robo1-cc3 Binding
(A) Domain organization model for the F-BAR, RhoGAP, and SH3 domains of srGAP2. Each domain is indicated and color coded as in Figure 1A.
(B) A graphical table that describes the mechanism that binds Robo1-cc3 to srGAP2, based on surface plasmon resonance (SPR) kinetic measurements of
Robo1-cc3 peptide to the 2SH3e, 2RSe, and 2BRSe srGAP2 constructs. Robo1-cc3 is depicted as a green coil with proline side chains. Weak ligand binding
(KD = 13.1 mM) to the isolated SH3 domain (top), with very fast on- and off-rates, is enhanced by the RhoGAP domain (KD = 4.49 mM), which may form a composite
binding site together with the SH3 domain. Binding is further strengthened by the F-BAR domain (KD = 0.59 mM), which stabilizes the RhoGAP-SH3 interdomain
arrangement, thereby facilitating a faster association rate. It is readily visible from the SPR sensograms (plotted as time versus response units) that very fast
Robo1-cc3 association and dissociation rates of 2SH3e are in sharp contrast to the slower rates recorded for 2BRSe and 2RSe. Note that the association with
2RSe is slower than with 2BRSe. Nevertheless, point mutations in the SH3 Px (Y781A) and xP (W765A) pockets abolish the Robo1-cc3 association (bottom
panel), thereby demonstrating the essential role of the SH3 domain in Robo1-cc3 binding.interaction using SPR. In both cases, no interaction was de-
tected (Figure 4). These results show strict dependence on the
integrity of the entire SH3 PxxP groove for ligand binding. In
conclusion, the PxxP groove of the SH3 domain is probably
the most basic element that initiates polyproline binding to
srGAP2; however, by itself it can only support weak interactions
(Figure 4).
C0 Extension Eliminates the Binding of a Non-specific
Ligand
We have shown that the C0 extension imparts moderate inhibi-
tion—up to a 3-fold difference in KD values—which does not
eliminate binding. We next considered what would be the impact
of the C0 extension upon binding of polyproline segments that
were previously confirmed as not having physiological interac-
tions with srGAP2. Like cc3, cc2 is also a conserved polyproline
Robo1 intracellular motif that mediates interactions with severalStructure 23, 1989–20intracellular effectors, but not with srGAPs (Wong et al., 2001).
UsingMST, wemeasured and compared theKD values for a syn-
thesized Robo1-cc2 26-amino-acid peptide (Figure S6) binding
to 2BRSe and 2BRS. Under these experimental conditions, we
detected no interaction with 2BRSe, while in the absence of
the C0 extension (2BRS), cc2 shows binding with an estimated
KD of 41 mM (Table 2 and Figure S7). This experiment points to
a potential role of the C0 extension in eliminating srGAP2 interac-
tions with non-specific partners such as Robo1-cc2.
P807 of the C0 Extension Is the Key for Autoinhibition
After demonstrating that the C0 extension autoinhibits protein
binding to srGAP2, we further analyzed the inhibitory mecha-
nism. Based on structure and sequence analyses detailed in
the previous sections (Figures 2 and 3), we focused on P807,
and tested whether a substitute of P807 will eliminate C0 exten-
sion autoinhibition. We noted a missense srGAP3 P823Q00, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 1995
Figure 5. SAXS 3D Structure and Domain
Organization of srGAP4
(A) SAXS 3D volume of full-length srGAP4 is rep-
resented as opaque (left) and transparent (right)
envelopes. A 30-A˚ resolution 3D volume was
converted from a bead model and showed two-
fold symmetry, with a center reminiscent of other
F-BAR structures, and extra densities at the ex-
tremities of the volume. The F-BAR domain of
PACSIN1 (PDB: 3HAH; in yellow) fitted the center
of the volume. Composite RhoGAP-SH3 struc-
tures (depicted in red and gray, respectively) were
derived from the RhoGAP Beta2-Chimaerin (PDB:
1XA6) and the 2SH3e (this work) crystal structures,
and docked to the tip densities.
(B) Superposition of the experimental scattering
curve obtained for srGAP4 (black) with the calcu-
lated scattering curves derived from the ab initio
model of srGAP4 (red). The Guinier plot is shown at
the top right.
(C) The P(r) function of srGAP4 data indicates
maximal dimensions (Dmax) of 267 A˚.mutation (srGAP3 P823 exactly aligns with srGAP2 P807, see
Figure 2) found in a patient with lung adenocarcinoma (Forbes
et al., 2011) and, therefore, chose to substitute srGAP2 P807
with glutamine for our experiments. Expression and purification
of 2BRSe P807Qwere the same as for the wild-type protein (Fig-
ure S1), and the binding affinity of 2BRSe P807Q to Robo1-cc3,
Gephyrin, and YLPM1 was measured using MST. In all three
cases, 2BRSe P807Q binds with similar or slightly stronger KD
values compared with those measured for 2BRS, which lacks
the C0 extension altogether (Table 2; Figures 3 and S7). These re-
sults demonstrate the importance of P807 in C0-extension inhibi-
tion and show that an xP-mimicry mechanism may be utilized to
inhibit polyproline binding.
Interestingly, in three other cases (the NADPH oxidase
subunit p47, and the Rlk and Itk non-receptor tyrosine kinases),
di-proline motifs juxta-located on carboxy- or amino-flanking re-
gions of SH3 domains mimic polyproline ligands, and thereby
block accessibility to the PxxP binding groove (Andreotti et al.,
1997; Groemping et al., 2003; Laederach et al., 2003). After
observing the mechanistic similarity in SH3 autoinhibition by
flanking di-proline motifs, we questioned how common this
mode of regulation of SH3 domains might be by analyzing the
flanking regions of unique human SH3 sequences with respect
to the presence and conservation of di-proline motifs. Our anal-
ysis showed that in 49 out of the 209 cases examined, conserved
di-proline motifs were found at a range of ±40 amino acids from
the SH3 boundaries (List S1), and that in the other 160 cases sin-
gle conserved prolines and PxxP motifs were common. From
this analysis, we conclude that autoinhibition of SH3 domains
by means of ligand mimicry may be a general mechanism for
eliminating non-specific binding to SH3 domains.
SAXS Outlines the Structure and Packing of the F-BAR,
RhoGAP, and SH3 Domains of Intact srGAP4
We showed that protein binding to SH3 is dramatically enhanced
by the F-BAR and RhoGAP domains of both srGAP2 and1996 Structure 23, 1989–2000, November 3, 2015 ª2015 Elsevier LtdsrGAP4, and hypothesized that this effect is due to a specific
intramolecular arrangement of the three domains. To obtain a
structural basis that will clarify these observations and hypothe-
ses, we determined the solution structure of full-length srGAP4
using SAXS (small-angle X-ray scattering), and assigned the
domain organization by fitting homologous crystal structures.
The shape of srGAP4 was determined ab initio, and the model
fit the experimental data with a c2 discrepancy of 0.83 (Figure 5
and Table 3).
This structure displays a two-fold symmetry, where two
srGAP4 protomers are tightly packed together along the long
axis of the molecule. Given its sequence similarity to other
F-BAR domains, it is not surprising that the core of the srGAP4
structure resembles in size and angular arrangement the canon-
ical helix bundle and extended arms, as seen in the crystal struc-
tures of FBP17 and FCHo2 (PDB: 2EFL and 3HAH). At the tips of
the F-BAR arms, additional densities that correspond in volume
to the RhoGAP and SH3 domains show close interactions to
each other and the F-BAR arms, thus supporting our previous
analysis of cooperative participation of the three domains in
ligand binding.
DISCUSSION
In this study, we investigated the mechanism of polyproline
ligand binding to srGAP2, and discovered two molecular ele-
ments that together facilitate higher affinity and greater speci-
ficity association than previously known. First, we showed that
the SH3 domain of srGAP2 is necessary but not sufficient for
effective ligand binding, and that the cooperative participation
of the F-BAR and RhoGAP domains provides an approximately
15-fold increase in binding affinity. The second element that
modulates srGAP2 associations is an SH3 carboxy extension
that occludes a portion of the SH3 PxxP binding groove, thereby
restricting access of the binding partners. Finally, depending on
the local concentration of srGAP2, the carboxy extension bindsAll rights reserved
Table 3. SAXS Statistics
Structural Parameters
Rg (A˚) (from Guinier) 87.4 ± 0.86
Dmax (A˚) 267
Porod volume estimate (A˚3) 400.8
DAMMIN excluded volume (A˚3) 450
Molecular Mass Determination
Vc (A˚
2) 14.77
Qr (A˚
3) 24.94
SAXS determined mass (kDa) 203
Theoretical mass (kDa) 210
Molecular mass Mr (kDa) (from Porod invariant) 200–250in cis or in trans to a neighboring srGAP2 molecule. We hypoth-
esize that the transition from the cis to trans states is triggered by
the recruitment of srGAP2 to the plasmamembrane, where inter-
molecular srGAP2 interactions form a membrane-associated
lattice.
The SH3 C0 Extension Is an Autoinhibitory Element for
Polyproline Binding to srGAP2
Here, we present structural and biochemical evidence revealing
the role of the SH3 carboxy extension (C0 extension) in the auto-
inhibition of protein binding to srGAP2. The C0 extension elimi-
nates the non-specific binding of the Robo1-cc2 segment, which
is not an srGAP2 ligand, and moderately inhibits the binding of
the previously confirmed srGAP2 binding partners: Robo1-cc3,
Gephyrin, and YLPM1. Our crystallographic studies revealed
the structure of the SH3 C0 extension that interacts in trans
with a symmetry-mate molecule to occupy the SH3 specificity
zone and the xP pocket. C0-extension-mediated trans interac-
tions also occur in solution, as demonstrated by CG-MALS,
with a dimerization dissociation constant of 1.39 mM. SH3 inter-
actions involving the specificity zone are not uncommon and, in
several documented cases (Saksela and Permi, 2012), SH3
domains interact with other proteins through expansion of the
binding surface from the PxxP groove to secondary SH3 binding
surfaces such as the ‘‘specificity zone,’’ thereby providing addi-
tional specificity and affinity. However, unlike canonical polypro-
line ligands, in our case the C0 extension does not cover the
entire PxxP binding groove but rather the xP cleft alone. This
way, the specificity zone seems to serve as a docking site that
places the minimal inhibitory element in the exact position to
cover the xP binding pocket, providing high specificity with a
moderate inhibitory effect. The way in which the C0 extension
residues interact with the xP pocket is a typical example of sub-
strate mimicry, in which proline 807 assumes the exact rotamer
and spatial positions, as do class I polyproline ligands (Lim et al.,
1994), with a hydrogen bond formed between the proline back-
bone carbonyl and the tryptophan indole amine. The evolu-
tionary conservation of srGAP2 P807 further highlights the
functional importance of this residue. The key role of P807 in
autoinhibition was demonstrated when the srGAP2 (2BRSe
construct) mutant, introduced with a P807Q substitute, abol-
ished the inhibitory activity of the C0 extension in binding
Robo1-cc3, Gephyrin, and YLPM1 ligands, and presented KD
values similar to those of the srGAP2 construct (2BRS), whichStructure 23, 1989–20lacks the C0 extension. We also demonstrated that the C0 exten-
sion can eliminate the binding of non-specific polyproline seg-
ments, as in the case of the Robo1-cc2. cc2 is also a conserved
polyproline cytoplasmic motif in Robo receptors that, unlike the
cc3 motif, is not involved in Robo1-srGAP2 interaction in cell
culture (Wong et al., 2001). While cc2 binds 2BRS with an
approximate KD of 43 mM, no binding to the 2BRSe construct
was detected, demonstrating the potential role of the C0 exten-
sion in eliminating non-specific interactions to srGAP2.
The F-BAR, RhoGAP, and SH3 Domains Cooperatively
Participate in Polyproline Ligand Binding
The binding affinity of Robo1-cc3, Gephyrin, and YLPM1 pep-
tides to the isolated srGAP2 SH3 domain is relatively weak,
with KD values ranging from 2.5 to 40.9 mM. However, much
stronger binding is measured for srGAP2 constructs that also
include the F-BAR and RhoGAP domains. Moreover, the binding
kinetics, asmeasuredbySPR, is fundamentally different for 2SH3
compared with the 2RS and 2BRS constructs. While Robo1-cc3
binding to the isolated SH3 domain has very fast on- and off-
rates, much slower rates were measured for the 2RS and 2BRS
constructs. It is noteworthy that while avidity might have been
considered as one of the factors contributing to stronger binding
in the 2BRS constructs due to its F-BAR-mediated dimeric struc-
ture, the 2RS constructs are strictly monomeric and still show
muchstrongerbinding than the isolated2SH3constructs. In spite
of the strong contribution of the F-BAR-RhoGAP domains to the
ligand binding, as reflected by the dramatic difference in KD, kon,
and koff between isolated 2SH3 and 2BRS constructs, point mu-
tations (Y781AandW765A) that target theSH3Px and xPbinding
pockets nevertheless abolished the binding, thereby demon-
strating that polyproline-srGAP2 interactions rely on the integrity
of the SH3 PxxP binding groove.
There are several documented precedents for composite
domains that facilitate high-affinity binding by forming a better
binding surface. One example is the interaction between the
two NADPH oxidase subunits, p47 and p22 (Groemping et al.,
2003). There, a polyproline segment of p22 simultaneously binds
the PxxP grooves of two consecutive p47 SH3 domains (desig-
nated SH3A and SH3B) which, together, form an elaborate bind-
ing surface. Similar to the F-BAR-RhoGAP domains of srGAP2,
which do not bind Robo1-cc3 independently (deduced from the
lack of Robo1-cc3 binding to the Y781A and W765A mutants),
SH3B of p47 by itself does not showp22 interaction. On the other
hand, dissociation constants of 7 mM for the binding of p22 to
SH3A and 0.4 mM for the tandem SH3A and SH3B domains
were calculated. These values are strikingly similar to the KD
values of 6.9 and 0.48 mM that we measured, using MST for the
binding of Robo1-cc3 to 2SH3 and 2BRS, respectively. Further
measurements of Robo1-cc3 to 2RS and 2RSe showed differ-
ences in the on- and off-rates in comparison with the 2BRS
constructs, and allowed better understanding of theway inwhich
certain polyproline-containing proteins associate with srGAP2.
The 14- or 21-fold difference (forMSTandSPR, respectively) in
KD values, and the dramatic differences in the on- and off-rates
between 2SH3 and 2BRS, led us to the conclusion that the
RhoGAP domain forms a composite ligand-binding surface
together with the SH3 domain, and that the role of the F-BAR
domain is in stabilizing their relative orientation to each other by00, November 3, 2015 ª2015 Elsevier Ltd All rights reserved 1997
Figure 6. Proposed Model for a Link between the Subcellular Local-
ization of srGAP2 and C0 Extension cis or trans Position
(A) srGAP2 is an F-BAR-mediated dimer that, when localized to the nucleus or
cytoplasm, is at a relatively low concentration that does not allow the C0
extension to interact in transwith other srGAP2molecules. The srGAP2 soluble
form allows only cis interactions, which moderately autoinhibit ligand binding.
(B) Upon its activation and recruitment to the membrane surface, srGAP2
forms an F-BAR-mediated oligomeric lattice that brings SH3 domains from
neighboring molecules into close proximity, thereby allowing C0 extension
interactions in trans. There, the C0 extension of a ‘‘donor’’ molecule binds to the
neighboring, ‘‘acceptor’’ molecule, while the C0 extension of the acceptor, due
to structural constraints, cannot reach the donor, leaving it exposed.allowing ten times faster on-rate ligand binding than with 2RS. It
is interesting that srGAP proteins were initially discovered by a
yeast two-hybrid screen against Robo receptors (Wong et al.,
2001), while a later screen that used isolated SH3 domains to
identify newsrGAP-bindingpartners failed topickupRobo recep-
tors (Okada et al., 2013). In light of our new knowledge about the
auxiliary role of the F-BAR and RhoGAP domains in polyproline
binding to the SH3 domain, this apparent discrepancy has been
settled. Future screenswill bemore effective if using larger srGAP
constructs when searching for new srGAP-binding partners.
Autoinhibition in cis and Lattice Interactions in trans:
Two Roles for One Short C0 Extension?
In the crystal structure of 2SH3e, the C0 extension of a donor
molecule interacts in trans with a symmetry-mate acceptor,
while the C0 extension of the acceptor cannot reach the donor’s
binding site. Instead, the symmetry mate binds another neigh-
boring molecule, and so on. In addition, in solution, CG-MALS
measurements showed that the C0 extension mediates the
dimerization of 2SH3e with a KD of 1.39 mM. However, C
0-exten-
sion interaction in cis is also evident, as the binding of polyproline
peptides is inhibited by the C0 extension when srGAP2 is in a
concentration range of 0.1–30 mM, in which 2SH3e is virtually
entirely monomeric in solution. In fact, analysis of the 2SH3e
crystal structure shows that it is sterically possible for the C0
extension to reach a cis binding position, at the expense of
several atomic contacts that exist in the trans conformation.
These results and analyses draw a picture in which trans interac-
tions occur under high local concentrations, while interactions in
cis occur at lower srGAP2 concentrations. We attribute these
high and low concentrations and the corresponding trans and1998 Structure 23, 1989–2000, November 3, 2015 ª2015 Elsevier Ltdcis C0-extension positions to actual physiological conditions in
the course of srGAP protein activity.
The F-BAR domain of srGAP2 binds to and reshapes plasma
membranes to form filopodia-like protrusions (Guerrier et al.,
2009). Judging from the uniform diameter and shape of these
protrusions and based on our current knowledge of how BAR
domains deform membranes (Frost et al., 2009), we posit that
the srGAP2 F-BAR domains form oligomeric lattices on mem-
brane surfaces that are held by lateral and tip-to-tip interactions
(Figure 6). Of special relevance to our case is the full-length cry-
oelectron-microscopic structure of endophilin in its membrane-
bound lattice form, as determined by Mim et al. (2012), who de-
pict how SH3 domains of neighboring molecules dimerize at the
proximal points of the N-BAR domain tips. A very high (3–5 mM),
effective concentration and the accurate positioning of the inter-
acting domains are thought to drive SH3 dimerization, thereby
contributing to the formation and stability of the endophilin lat-
tice. Similarly, we hypothesize that SH3 domains of neighboring
membrane-bound srGAP2 molecules are placed in close prox-
imity to each other, bringing about a high, effective concentration
that exceeds the 2SH3e 1.39-mM dimerization constant. Such
proximity may promote the C0 extensions to form trans interac-
tions with a neighboring molecule at the expense of the weaker
cis contacts. The observation made by Guerrier et al. (2009)
that tryptophan 765 (the SH3 docking site for the C0 extension)
is critical for srGAP2 filopodia-like formation in COS-7 cells
may reflect a vital role for C0-extension-mediated intermolecular
interactions in the membrane-associated srGAP2 lattice.Conclusions
In this study, we show that the F-BAR and RhoGAP domains
participate in cooperative ligand binding to the SH3 domains of
srGAP2 and srGAP4. The dramatic differences in KD, kon, and
koff indicate that the RhoGAP and SH3 domains form a compos-
ite surface that binds polyproline segments better than the iso-
lated SH3 domain, and that the F-BAR domain stabilizes this
surface. We also show that protein binding to srGAP2 is inhibited
by an SH3-carboxy extension (C0 extension) that interacts with
the specificity zone and xP cleft of the SH3 domain, and has
the capability of eliminating the binding of the non-specific,
Robo1-cc2 polyproline segment. At high srGAP2 concentra-
tions, the C0 extension binds in trans to another srGAP2molecule
(KD = 1.39 mM). We hypothesize that the trans position reflects a
second role that the SH3 domain fulfills in the context of mem-
brane-associated srGAP2, where SH3-SH3 lateral interactions
contribute to the stability and structure of the, primarily F-BAR-
mediated, lattice.EXPERIMENTAL PROCEDURES
Crystallization, Data Collection, and Structure Determination
Purified 2SH3e was screened for crystallization using the commercial screens
CrystalScreen HT, PegRx HT, and SaltRx HT (Hampton Research), in 96-well
hanging-drop clear polystyrene microplates (Corning Life Sciences) at 4, 12,
and 20C, respectively. A 1:1 sample/reservoir ratio was used, with a final drop
size of 0.3 ml. Eight weeks after setup, a single crystal hit appeared at 4C in
2.0 M ammonium sulfate. The crystallization condition was further refined
using 24-well hanging-drop vapor-diffusion plates by varying pH values and
precipitant and protein concentrations. Best diffracting crystals were obtained
when the protein concentration was 19 mg/ml, with a reservoir content ofAll rights reserved
2.35 M ammonium sulfate and 0.1 MMES (pH 6.25) at 4C. Crystals appeared
after about 8 weeks in 2-ml drops (protein/reservoir ratio of 1:1), and were har-
vested 4 weeks after appearance. The crystals were cryoprotected by adding
13.5% glycerol to the mother liquor solution before harvesting, and flash-
frozen in liquid nitrogen.
Diffraction data for the 2SH3e crystals were measured on beamlines ID23-1
(Nurizzo et al., 2006) and ID29 (de Sanctis et al., 2012) at the ESRF and ID14.1
(Mueller et al., 2012) at BESSY II, and were processed and scaled using the
XDSAPP software package (Krug et al., 2012). Molecular replacement and
initial model building were carried out using the BALBES server (Long et al.,
2008), which placed the two 2SH3e molecules in the asymmetric unit. Further
manual model building and refinement were performed using Coot (Emsley
et al., 2010), Phenix-refine (Adams et al., 2010; Afonine et al., 2012), and the
ReDo server (Joosten et al., 2012). Data collection and refinement statistics
are summarized in Table 1.
BioSAXS Analysis
SAXS experiments were conducted at the ESRF BM29 beamline, where an on-
line high-performance liquid chromatography system (Viscotek GPCmax;Mal-
vern Instruments) was attached directly to the sample-inlet valve of the sample
changer. srGAP4 samples at a concentration range of 0.5–5 mg/ml were
loaded into vials and automatically injected into the column (Superdex 200
10/300 Gl; GE Healthcare) via an integrated syringe system. Prior to each
run, the column was equilibrated with 1.5-column volumes of buffer (25 mM
phosphate buffer [pH 8], 200 mM NaCl, and 1 mM DTT), and the baseline
was monitored. All data were collected at a wavelength of 0.9919 A˚ using a
sample-to-detector (PILATUS 1M; Dectris) distance of 2.81 m, corresponding
to an s range of 0.08–4.5 nm. Approximately 3,600 frames (1 frame per second)
were collected per 60-min sample run. Initial data processing was performed
automatically using the EDNA pipeline, generating radially integrated, cali-
brated, and normalized one-dimensional profiles for each frame. All frames
were compared with the initial frame, and matching frames were merged to
create the reference buffer. Any subsequent frames that differed from the
reference buffer were subtracted and then processed within the EDNA pipe-
line. The invariants calculated by the ATSAS tool (AUTORG) were used to
select a subset of frames from the peak scattering intensity. Frames with a
consistent Rg from the peak scattering intensity were merged to yield a sin-
gle-averaged frame corresponding to the scattering of an individual size-
exclusion chromatography-purified species.
The averaged scattering data were further evaluated using PRIMUS. The
isotropic scattering intensity I(q) was transformed to the distance distribution
function P(r) using the program GNOM, which was also used to calculate the
particle maximum dimensions Dmax. Dmax was considered to be optimal
when the Rg obtained from the P(r) plot was equal to that obtained from the
Guinier analysis. For ab initio modeling of the SAXS data, 20 sets of indepen-
dent models were calculated using DAMMIN applying two-fold symmetry,
then averaged and aligned using DAMAVER. Molecular masses were deter-
mined as described by Rambo and Tainer (2013).
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